StockStory.org on MSN
Vertex Pharmaceuticals (VRTX) stock trades up, here is why
What Happened? Shares of biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) jumped 3.8% in the afternoon session after ...
Fintel reports that on January 6, 2026, Wolfe Research upgraded their outlook for Vertex Pharmaceuticals (NasdaqGS:VRTX) from ...
Now, it’s worth noting Stock Advisor’s total average return is 966 % — a market-crushing outperformance compared to 194% for ...
Andrew Hill Investment Advisors reports that client portfolios achieved double digit gains during 2025. Review our defensive ...
Nasdaq Inc’s stock reached an all-time high of 99.6 USD, marking a significant milestone for the company. With a market capitalization of $56.68 billion, the stock is currently ...
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) recently garnered an ‘Outperform’ rating from Andy Chen of Wolfe Research, reflecting a bullish outlook and a potential upside for investors. The ...
Zenas BioPharma, Inc. (ZBIO) garnered attention in the financial community as Morgan Stanley analyst Judah Frommer assigned it an “Equal-Weight” rating. With a price target set at $37, this rating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback